,i #aagth ,,congress #ast ,session ,h4 ,r4 #eihi ,,in ,,the ,,house ,,of ,,representatives ,november #af1 #bjba,mr4 ,swalwell 7for himself1 ,mr4 ,peters1 and ,mr4 ,emmer7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to conduct a demonstration program to genetic and genomic testing for certain children1 to provide for a study by the ,national ,academy of ,medicine on the use of such testing to improve health care1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,precision ,medicine ,answers for ,kids ,today ,act4 #b4 ,centers for ,medicare ,medicaid ,services ,guidance on the ,early and ,periodic ,screening1 ,diagnostic1 and ,treatment ,benefit ,not later than #f months after the date of enactment of this ,act1 the ,centers for ,medicare ,medicaid ,services shall issue guidance to ,states on authority and requirements under the ,medicaid program under title ,,xix of the ,social ,security ,act to provide medically necessary health care that falls within the scope of services specified under section #aije7r7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;d7r77 to a child1 regardless of whether the service is available for adults under the ,state plan 7or waiver of such plan7 under such title4 ,the guidance shall-- 7#a7 include technical and educational assistance on how to increase the frequency of coverage under the ,state plan 7or waiver7 pursuant to paragraphs 7#d7 and 7#af7 of section #aije7;a7 of such ,act 7#db ,u4,s4,c4 #acif;d7a77 for genetic and genomic testing diagnostic services1 including whole exome sequencing1 whole genome sequencing1 and gene panels when recommended by a qualified treating provider as a first- or second-tier test for pediatric patients1 including those who-- 7,a7 have a positive result from a newborn screening program2 7,b7 have one or more neurodevelopmental or congenital anomalies2 7,c7 are experiencing developmental delay or intellectual disability2 7,d7 are having seizures2 7,e7 have been referred or admitted to a pediatric or neonatal intensive care unit for a chronic or undiagnosed disease2 7,f7 have been seen by at least one medical specialist for such chronic or undiagnosed disease2 or 7,g7 are suspected by at least one healthcare provider to have a neonatal- or pediatric-onset genetic disease2 7#b7 provide education and support to providers to minimize denials of claims for medical assistance under the ,state plan under title ,,xix of the ,social ,security ,act resulting from deficient or inadequate paperwork2 and 7#c7 ensure that providers and ,medicaid-eligible children and the families are aware of the ,early and ,periodic ,screening1 ,diagnostic and ,treatment ,benefit under title ,,xix of the ,social ,security ,act and have access to required screenings and necessary treatment services4 #c4 ,,demonstration ,,program ,,to ,,provide genetic and genomic testing for ,,certain ,,children 7a7 ,in general ,the ,secretary of ,health and ,human ,services shall enter into agreements with up to #ae ,states submitting applications under subsection 7c7 for the purpose of conducting1 in accordance with this section1 #c-year demonstration projects under section #aaae of the ,social ,security ,act 7#db ,u4,s4,c4 #acae7 in such ,states during the #c-year period beginning on the first date of the first fiscal quarter than begins on or after the date of the enactment of this section to test and evaluate the provision of medical assistance under the ,state plans under title ,,xix of such ,act 7or waivers of such plans7 to eligible individuals for purposes of providing such individuals with genetic and genomic testing4 7b7 ,demonstration project payment requirements ,under each demonstration project under this section conducted by a ,state1 the following shall apply3 7#a7 ,the ,state shall provide a health care provider 7as defined by the ,state7 with payments for the provision of genetic and genomic testing to any eligible individual4 ,payments made to a health care provider for such services shall be treated as medical assistance for purposes of section #aijc7;a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;b7a771 except that the ,federal medical assistance percentage applicable to such payments shall be equal to #ajj percent4 7#b7 ,the ,state shall specify the methodology the ,state will use for determining payment for the provision of genetic and genomic testing4 ,such methodology for determining payment shall be established consistent with section #aijb7;a77#cj77;,a7 of such ,act 7#db ,u4,s4,c4 #acif;a7a77#cj77;,a774 7c7 ,applications 7#a7 ,in general ,a ,state desiring to enter into an agreement under subsection 7a7 with the ,secretary for conducting a demonstration project shall submit to the ,secretary an application1 in accordance with such form and manner1 and application priorities1 as specified by the ,secretary and that at a minimum includes the following3 7,a7 ,an explanation of how and the extent to which genetic and genomic testing under the demonstration project of the ,state will provide information and data on how such services improve the diagnosis of eligible individuals4 7,b7 ,an explanation of how and the extent to which coverage under the ,state plan 7or waiver7 pursuant to the demonstration project will increase the use of genetic and genomic testing that may increase the use of genetic and genomic testing that may improve clinical outcomes for eligible individuals4 7,c7 ,procedures for referring any eligible individual who seeks or needs treatment in a hospital emergency department to a health care provider who is qualified 7as determined by the ,state7 to provide genetic and genomic testing4 7,d7 ,an explanation of how genetic and genomic testing may improve health outcomes for all populations in the ,state1 including-- 7i7 individuals with a rare genetic disease1 including a metabolic disease1 neurologic disorders1 or hereditary cancer testing in the presence of a suspected or confirmed cancer diagnosis2 and 7ii7 special populations1 including infants and children who are critically ill 7non-infectious and non-trauma7 patients1 transplant patients1 individuals with cardiac disease1 and individuals with1 or who have a family history of1 a birth defect or developmental disability4 7#b7 ,preferences in considering applications ,in considering applications submitted under paragraph 7#a71 the ,secretary of ,health and ,human ,services shall give preference to ,states that can demonstrate underutilization of genetic and genomic sequencing clinical services 7with priority given to ,states that do not cover whole-genome sequencing or do not cover the majority of genetic and genomic clinical services7 in pediatric populations under the ,state plan under title ,,xix of the ,social ,security ,act 7or waiver of such plan74 7d7 ,technical assistance ,the ,secretary of ,health and ,human ,services shall provide technical assistance to assist ,states in planning and designing the demonstration project for purposes of applying for conducting such project under this section4 7e7 ,reports by ,states ,not later than one year after the date on which a ,state enters into an agreement under subsection 7a7 with the ,secretary for conducting a demonstration project1 the ,state shall submit a report to the ,administrator of the ,centers for ,medicare ,medicaid ,services and the ,administrator of the ,health ,resources and ,services ,administration on the extent to which genetic and genomic testing improved outcomes and reduced health disparities4 ,such report shall include information on the number of patients receiving genetic and genomic testing1 the types of services provided1 and such other information as the ,secretary shall prescribe4 7f7 ,reports by health care providers ,as a condition for receiving payment for genetic and genomic testing provided to an eligible individual under a demonstration project conducted by a ,state under this section1 a health care provider shall report to the ,state1 in accordance with such requirements as the ,secretary shall specify1 on all applicable measures for determining the quality and efficacy of such services4 7g7 ,definitions ,in this section3 7#a7 ,eligible individual ,the term eligible individual means1 with respect to a ,state1 an individual who-- 7,a7 is eligible for medical assistance under the ,state plan under title ,,xix of the ,social ,security ,act 7or a waiver of such plan72 7,b7 is under the age of #ba 7or1 at the option of the ,state1 under the age of #bj1 #ai1 or #ah as the ,state may choose71 or in the case of an individual described in section #aijb7;a77#aj77;,a77i77,,ix7 of such ,act 7#db ,u4,s4,c4 #acif;a7a77#aj77;,a77i77,,ix771 under the age of #bf2 7,c7 has been referred or admitted to an intensive care unit1 or has been seen by at least one medical specialist1 for a suspected genetic or undiagnosed disease2 or 7,d7 is suspected by at least one medical specialist to have a neonatal-onset or pediatric-onset genetic disease4 7#b7 ,genetic and genomic testing ,the term genetic and genomic testing1 with respect to an eligible individual-- 7,a7 means the determination of a sequence of deoxyribonucleic acid bases in the genome of such individual1 and1 if for the sole benefit of the individual1 a biological parent of such individual for the purpose of determining whether one or more potentially disease-causing genetic variants are present in the genome of such individual or such biological parent2 and 7,b7 includes-- 7i7 the sequencing of the whole genome1 the whole exome1 or a panel of genes2 and 7ii7 any analysis1 interpretation1 and data report derived from such sequencing4 #d4 ,national ,academy of ,medicine study 7a7 ,in general ,not later than one year after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services shall enter into an arrangement with the ,national ,academy of ,medicine under which the ,academy agrees to study-- 7#a7 how genetic and genomic testing may improve preventative care and precision medicine2 7#b7 disparities in access to precision diagnostics and associated therapeutics2 7#c7 how genetic and genomic testing may be used to reduce health disparities in marginalized communities2 7#d7 how the ,federal ,government may help to reduce barriers to genetic and genomic testing1 including-- 7,a7 encouraging the expansion of health insurance coverage of genetic and genomic testing1 including diagnostic1 predictive1 and presymptomatic testing1 and genetic and genomic testing 7as defined in section #b7;h77#b772 7,b7 supporting the collection of evidence for the clinical utility and appropriate use of genetic and genomic tests2 and 7,c7 improving access to genetic counselors1 pathologists1 and other relevant professions1 including strengthening related workforce education and training efforts2 7#e7 7,a7 the extent to which coverage provisions in the ,medicare and ,medicaid programs under titles ,,xviii and ,,xix of the ,social ,security ,act 7#db ,u4,s4,c4 #acie et seq41 #acif et seq47 may restrain the use of genetic and genomic testing that may improve clinical outcomes for beneficiaries2 7,b7 the extent to which coverage provided pursuant to section #b increased the use of genetic and genomic testing and improved clinical outcomes for beneficiaries2 and 7,c7 how the ,centers for ,medicare ,medicaid ,services may make coverage determinations that better suit a precision medicine approach to treatment2 and 7#f7 how genetic and genomic testing may improve health outcomes for all pediatric populations in the ,united ,states1 including-- 7,a7 children with a rare disease1 including a metabolic disease1 neurologic disorder1 or hereditary cancer testing in the presence of a suspected or confirmed cancer diagnosis2 and 7,b7 special populations1 including-- 7i7 critically ill 7non-infectious and non-trauma7 patients2 7ii7 transplant patients2 7iii7 individuals with cardiac disease2 and 7iv7 individuals with1 or who have a family history of1 a birth defect or developmental disability4 7b7 ,report 7#a7 ,in general ,the arrangement under subsection 7a7 shall provide for the ,national ,academy of ,medicine to submit1 not later than #b years after the date of enactment of this ,act1 a report on the results of the study under subsection 7a7 to-- 7,a7 the ,secretary of ,health and ,human ,services2 7,b7 the ,committee on ,ways and ,means and the ,committee on ,energy and ,commerce of the ,house of ,representatives2 and 7,c7 the ,committee on ,finance and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate4 7#b7 ,consultation ,the arrangement under subsection 7a7 shall provide for the ,national ,academy of ,medicine1 in developing the report required by paragraph 7#a71 to consult with physicians1 other health professionals1 health educators1 health professional organizations1 relevant companies1 patients1 patient organizations1 the ,health ,resources and ,services ,administration1 the ,national ,cancer ,institute1 the ,national ,institutes of ,health1 the ,agency for ,healthcare ,research and ,quality1 and the ,centers for ,medicare ,medicaid ,services4 7#c7 ,use of information ,the ,national ,academy of ,medicine shall1 to the extent possible1 in conducting the study under subsection 7a71 utilize information included in the reports submitted pursuant to subsections 7f7 and 7g7 of section #b4 #e4 ,centers for ,medicare ,medicaid ,services report on ,medicaid ,coverage for genetic and genomic testing ,not later than one year after the date of the enactment of this ,act1 and annually thereafter for the subsequent #c years1 the ,centers for ,medicare ,medicaid ,services shall submit to the ,secretary of ,health and ,human ,services1 the ,committees on ,ways and ,means and on ,energy and ,commerce of the ,house of ,representatives1 and the ,committees on ,finance and ,health1 ,education1 ,labor1 and ,pensions of the ,senate a report on the extent to which each of the #ej ,states provide coverage under the ,state plan under title ,,xix of the ,social ,security ,act 7or waiver of such plan7 of genetic and genomic testing 7as defined in section #b7;f77#b77 7including whole exome1 whole genome1 gene panels1 single gene tests1 ,chromosomal microarray analysis1 ,fluorescence in situ hybridization1 and other genetic and genomic tests71 including information on-- 7#a7 how often genetic and genomic diagnostic testing services are covered and reimbursed2 7#b7 the frequency of denials for coverage and the rationale for denying coverage2 7#c7 an analysis of which genetic and genomic diagnostic tests are being approved or denied2 7#d7 how often test genetic counseling is covered pre- and post-genetic and genomic diagnostic testing2 7#e7 the turn-around time for prior authorization requests2 and 7#f7 any barriers to coverage of genetic and genomic testing services identified4